';
Medical Rehab

RCPA is excited to share our growing list of sponsors and exhibitors who are committed to supporting our 2025 Conference Strive to Thrive! This event, which will be held September 9 – 12 at the Hershey Lodge, is a highlight for the PA health and human services fields. We would like to thank the organizations who have committed their support already; you can view them below as well as on our Conference website!

The conference is only four months away! We will soon be assigning booth numbers to exhibitors, and there are still many opportunities available for sponsorship and exhibit booths. Don’t delay! View this year’s Sponsors, Exhibitors, and Advertiser Brochure, which features detailed lists of all the ways your organization can thrive at our conference. These include networking opportunities in Connections Hall and new sponsorship items, such as the registration table!

Sign Up Now!
Sponsors, exhibitors, and advertisers who wish to be listed on the website, the mobile app, and in the conference program must submit all materials by August 20. The association looks forward to welcoming you at the conference! Space and opportunities are reserved on a first-come, first-served basis, and no reservation is considered complete without payment. If questions remain, please contact Carol Ferenz, Conference Coordinator.

View our sponsors and exhibitors at our Conference website!

The Brain Injury Advisory Board, established under section 1252 of the Federal Traumatic Brain Injury Act of 1996 (42 U.S.C. § 300d-52), will hold their next public meeting on May 2, 2025, from 10:00 am – 3:00 pm. The meeting will be held in person at the Pennsylvania Training and Technical Assistance Network (PaTTAN), 6340 Flank Drive, Harrisburg, PA 17112 in the Cumberland conference room.

Meeting materials will be sent out before the meeting and will also be available on the Board’s website as well as at the meeting location. Questions should be directed to Nicole Johnson electronically.

The Department of Health’s (DOH) Head Injury Program (HIP) strives to ensure that eligible individuals who have a traumatic brain injury receive high quality rehabilitative services aimed at reducing functional limitations and improving quality of life. The Board assists the Department in understanding and meeting the needs of persons living with acquired brain injuries, both traumatic and nontraumatic, and their families. This quarterly meeting will provide updates on a variety of topics, including the number of people served by HIP. In addition, meeting participants will discuss budgetary and programmatic issues, community programs relating to traumatic and nontraumatic brain injuries, and available advocacy opportunities.

For additional information or for persons with a disability who wish to attend the meeting and require an auxiliary aid, service or other accommodation to do so, contact Nicole Johnson, Division of Community Systems Development and Outreach, via email or at (717) 772-2763. For individuals with speech and/or hearing-impairments, contact V/TT (717) 783-6514 or the Pennsylvania Hamilton Relay Service at (800) 654-5984.

0 1388

Last week, the Centers for Medicare and Medicaid Services (CMS) released the Fiscal Year (FY) 2026 Inpatient Rehabilitation Facility (IRF) Prospective Payment System (PPS) proposed rule, as well as an accompanying fact sheet. The rule does not include proposed changes to the IRF coverage requirements. On the payment side, the rule would provide an overall 2.8% increase to estimated payments per discharge, compared to the 2.5% payment update that CMS finalized for FY 2025. The rule is more substantive with respect to the future Quality Reporting Program (QRP) changes. Specifically, the rule proposes to remove certain quality measures and standardized patient assessment data elements (SPADE) implemented in recent years relating to COVID-19 vaccination and social determinants of health (SDOH), and to modify the process for reconsideration of IRF QRP non-compliance penalties. Finally, the rule includes various requests for information (RFI), soliciting feedback on the IRF QRP and IRF-Patient Assessment Instrument (PAI).

The proposed rule will be published in the Federal Register on April 30, 2025. RCPA will provide a more detailed overview of the proposed rule following this date. Comments on the rule are due to CMS by June 10, 2025.

This community-focused advocacy forum brings together experts and stakeholders to discuss the local impact of federal funding cuts to Medicaid, particularly on vulnerable populations and essential services.

The event will be moderated by Chip Minemyer, publisher of The Tribune-Democrat, and panelists will include RCPA Honorary Board Member Jim Cook, who serves as Executive Director of Cambria Residential Services.

The event will be held Monday, April 21, at 6:30 pm. You can view the flyer here for more details.

Treating Functional Neurologic Disorder (FND) — “Not Your Parent’s Functional Neurologic Disorder”

Tuesday, May 20, 2025
1:00 pm – 2:00 pm EDT; 12:00 pm – 1:00 pm CDT;
11:00 am – 12:00 pm MDT; 10:00 am – 11:00 am PDT
Register Here

Presenter Bios:

Samuel Zachary, MOT, OTR/L
Sam is an occupational therapist at Children’s Hospital of Philadelphia (CHOP) in the inpatient rehabilitation and amplified musculoskeletal pain syndrome (AMPS) programs. Sam brings experience from a variety of medical-based pediatric settings, including acute care, in-patient rehabilitation, and multi-disciplinary outpatient clinics.

Over the past four years, Sam’s practice has focused on the AMPS Intensive Program and Clinic at CHOP. He is passionate about treating children and adolescents with AMPS, functional neurological disorder, or both. He brings great enthusiasm while sharing his knowledge and best practices for caring for this unique population.

Lori Kile, PTA

Lori is a physical therapist assistant at Children’s Hospital of Philadelphia (CHOP) working in the inpatient rehabilitation and amplified musculoskeletal pain syndrome (AMPS) programs. She began her career at CHOP in 1998 and has dedicated over 25 years of service to the institution. She worked in a variety of pediatric settings, including outpatient, acute care, and inpatient rehab, prior to finding her passion for treating youth and teens with Amplified Musculoskeletal Pain and Functional Neurological Disorder. Lori now specializes with these populations; she is also involved with the International FND society, where she helps to develop deliverables and build the knowledge base regarding the diagnosis. She loves to share her knowledge and lessons learned to build the skills of others and promote best practices in treatment of patients with FND.

Objectives: Following this course, the learner will:

  • Identify recent changes in the understanding, diagnosis, and treatment of pediatric patients with FND.
  • Obtain a best practice framework for treating pediatric patients in the rehabilitation setting.
  • Learn about best practice for measuring outcomes with pediatric patients with FND.

Audience: This webinar is intended for all interested members of the rehabilitation team.

Level: Beginner

Certificate of Attendance: Certificates of attendance are available for all attendees. No CEs are provided for this course.

Complimentary webinars are a benefit of membership in IPRC/RCPA. Registration fee for non-members is $179. Not a member yet? Consider joining today.

The team at Greenspace Health are hosting a timely and insightful panel to explore the evolving role of Measurement-Based Care (MBC) in accreditation and clinical practice. The session, Measurement-Based Care & CARF Accreditation: Driving Quality Through Measurable Outcomes, brings together an exceptional group of experts to discuss how organizations can leverage MBC to improve outcomes, align with accreditation standards, and elevate care quality across their services. The webinar will be held May 15 at 1:00 pm EDT. Register here.

Speakers include:

  • Michael Johnson, Senior Managing Director of Behavioral Health at CARF;
  • Dr. Kimberly Gordon-Achebe, Medical Director of Mobile Response and Stabilization Services at iMind Behavioral Health, a CARF accredited organization leveraging MBC;
  • Dr. James Boswell, Associate Professor and Director of Clinical Training at the University at Albany; and
  • Host: Jeremy Weisz, CEO and Co-Founder at Greenspace Health.

Whether you’re preparing for CARF accreditation, already using MBC, or exploring how to integrate it into your practice, this webinar will offer actionable insights, real-world strategies, and guidance on meeting CARF’s updated 2025 standards which now require ongoing progress measurement.

If you are unable to participate live, you can still register to receive the recording and resources after the session.

The Office of Developmental Programs (ODP) has shared an important announcement from the U.S. Food and Drug Administration (FDA) regarding an expanded recall on the SmartDrive Speed Control Dial by Max Mobility/Permobil due to the motor being unresponsive to the user.

Summary:

  • Max Mobility/Permobil has expanded the recall of the Speed Control Dial, a wired control option for the SmartDrive MX2+ Power Assist Device, due to safety and performance concerns.
  • This frame-mounted Speed Control Dial can be easily mounted to a wheelchair to allow for close access and easy pressing.
  • The recall was originally initiated on December 20, 2024, and has been expanded to address recalled products that may have been inadvertently comingled with redesigned product and shipped after December 20, 2024.
  • Those impacted by the expansion of the recall will be contacted with additional instructions.
  • This recall, as expanded, impacts all Speed Control Dials manufactured and distributed between the dates of August 17, 2023, through March 10, 2025.
  • As of March 27, 2025, Max Mobility/Permobil has received 781 complaints associated with the Speed Control Dial. As of March 27, 2025, five (5) serious injuries have been reported for this issue.
  • The reported serious injuries include a fractured hip, fractured tibia, fractured malleolus bone, broken ribs, and a concussion.

Background:

Max Mobility/Permobil Brand – (model number: MX2-3DCK/MX2-3DC): The frame-mounted Speed Control is easily mounted to a wheelchair to allow for close access and easy pressing. The Speed Control Dial can be used to deactivate the SmartDrive motor, as well as provide a means of actively powering the motor.

Recommendations:

To reduce the likelihood of a hazardous situation, discontinue use of the Speed Control Dial and utilize an alternate wired controller (Switch Control buttons or Switch Control with mono jack and mechanical switch) or wearable controller (compatible Apple Watch or Samsung Galaxy Watch Wear OS app).

If you have purchased a Speed Control Dial(s) with the above model numbers, you will need to request replacement Speed Control Dial units.

Refer to the FDA Original Press Release for instructions on requesting a replacement and additional information.